Related Experiment Video
Updated: Apr 19, 2026

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
Published on: March 8, 2018
Relationship between blood glucose fluctuation and macrovascular endothelial dysfunction in type 2 diabetic patients
X-G Zhang1, Y-Q Zhang, D-K Zhao
1Department of Endocrinology, General Hospital of Beijing Military Area, Beijing, PR China. xiaofenglv7966@163.com.
Insights
Blood glucose fluctuation, measured by continuous glucose monitoring, is linked to macrovascular dysfunction in type 2 diabetes mellitus (T2DM) patients. This heightened glucose variability may contribute to coronary heart disease (CHD) development.
Area of Science:
- Endocrinology
- Cardiology
- Metabolic Syndrome
Background:
- Type 2 diabetes mellitus (T2DM) is associated with macrovascular complications, including coronary heart disease (CHD).
- The role of glycemic variability, beyond average glucose levels, in the pathogenesis of macrovascular dysfunction in T2DM remains an area of active investigation.
Purpose of the Study:
- To investigate the association between blood glucose fluctuation and macrovascular dysfunction in patients with T2DM.
- To explore the relationship between glycemic variability parameters and markers of inflammation and endothelial function.
Main Methods:
- A 72-hour continuous glucose monitoring (CGM) was performed in 88 T2DM patients (with or without CHD) and 30 healthy controls.
- Brachial artery flow-mediated dilation (FMD) was assessed to evaluate endothelial function.
- Parameters of glucose excursion, including MAGE, LAGE, MPPGE, MODD, and IAUC70, were analyzed along with HbA1c, fasting insulin, and CRP.
Main Results:
- T2DM patients with CHD exhibited significantly greater blood glucose fluctuation compared to T2DM patients without CHD and healthy controls.
- Blood glucose fluctuation demonstrated significant correlations with flow-mediated dilation (FMD), C-reactive protein (CRP), and homeostatic model assessment of insulin resistance (HOMA-IR).
Conclusions:
- Elevated blood glucose fluctuation is a significant factor influencing inflammatory responses in T2DM patients.
- Increased glycemic variability may play a crucial role in the development and progression of coronary heart disease in individuals with type 2 diabetes mellitus.
Objective:
To evaluate the relationship between blood glucose fluctuation and macrovascular dysfunction.
Patients And Methods:
Eighty-eight type 2 diabetes mellitus (T2DM) patients with or without coronary heart disease (CHD) and 30 healthy control subjects were recruited. Glycosylated hemoglobin A1c (HbA1c), fasting insulin (FIns), and C-reaction protein (CRP) and some other general clinical variables were measured. A 72-hour continuous glucose monitoring (CGM) and brachial artery endothelium-dependent flow-mediated dilation (FMD) assessment were performed. The glucose excursion, MAGE (mean amplitude of glycemic excursions), LAGE (largest amplitude of glycemic excursions), MPPGE (mean postprandial glycemic excursions), MODD (absolute means of daily differences), and IAUC70 (incremental area under the curve below 70 mg/dl) during the CGM were analyzed. Correlations between the various variables were analyzed.
Results:
Enhanced blood glucose fluctuation was observed in T2DM patients with CHD as compared to other participants. And blood glucose fluctuation was correlated with FMD, CRP and HOMA-IR.
Conclusions:
Blood glucose fluctuation is an important factor that affects inflammatory response and possibly induces CHD in T2DM patients.
More Related Videos
Related Concept Videos
Diabetic Retinopathy
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Coronary Artery Disease I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Coronary Artery Disease II: Pathophysiology

